Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of COPD Co-infection With Tuberculosis on Th17 Cell Differentiation and Its Significance

NCT04966052 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT04966052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04966052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of COPD Co-infection With Tuberculosis on Th17 Cell Differentiation and Its Significance
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Completed
Start date
April 1, 2018
Completion date
June 1, 2020
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease, tuberculosis infection